compname announces board approval to continue the company's merger with Charter Community Foundation.
qtrly results on a diluted basis.
q1 revenue $892.4 million versus refinitiv ibes estimate of $87.6 million.
q4 revenue $710.8 million versus refinitiv ibes estimate of $697.4 million.
q2 sales rose 2.2%.
qtrly international revenues of $181.6 million versus refinitiv ibes estimate of $177.4 million.
sees fy 2020 net sales up 1.8%.
sees q4 and full-year 2021 results to be negatively impacted by exiting several patient transportation contracts and manufacturing and industrial services programs.
q2 sales rose 10 percent to $1,553 million.
compname posts q4 gross profit $368.7 million versus refinitiv ibes estimate of $359.5 million.
q4 gross profit was negatively impacted by estimated reductions in gross margins due to reclassification of certain expenses from sg&a to cost of revenues.
q4 earnings per share $1.87.
q4 adjusted non-gaap earnings per share $0.46 excluding items.
qtrly adjusted non-gaap earnings from operations of $170.4 million, or 19.1% of q4 2021 revenue.
compname reports q3 net interest expense $23.3 million.
qtrly net income $4.9 billion versus $4,868.2 million.
